CONTROLLED ADMINISTRATION OF BENEFICIAL AGENT TO BLOOD.
    1.
    发明公开
    CONTROLLED ADMINISTRATION OF BENEFICIAL AGENT TO BLOOD. 失效
    GESTEUERTE VERABREICHUNG EINES HEILMITTELS一个BLUT。

    公开(公告)号:EP0341291A4

    公开(公告)日:1990-07-03

    申请号:EP89900112

    申请日:1988-11-08

    Applicant: BAXTER INT

    CPC classification number: A61M1/3672 A61M1/3673

    Abstract: As one administers blood through a conduit (10) into a container (12), the blood is passed in the conduit across the supply of beneficial agent (18), such as anticoagulant, to cause a controlled amount of beneficial agent to enter the passing blood in a manner that is substantially uniform overtime. The beneficial agent (18) is typically in dry form until it enters into contact with the blood. Accordingly, no substantial portion of the blood is exposed to a significantly higher concentration of the beneficial agent than other portions of the blood.

    Abstract translation: 当通过导管(10)将血液施用到容器(12)中时,血液在管道中通过有益剂(18)的供应,例如抗凝血剂,以引起受控量的有益剂进入通过 血液的加班时间基本一致。 有益剂(18)通常是干燥形式,直到其与血液接触。 因此,与血液的其他部分相比,没有相当一部分血液暴露于有益剂量的明显更高的浓度。

    IRRADIATION OF BLOOD PRODUCTS
    2.
    发明专利

    公开(公告)号:CA2031522C

    公开(公告)日:1998-08-25

    申请号:CA2031522

    申请日:1990-01-17

    Applicant: BAXTER INT

    Abstract: A thin film (10) or layer (10) of white blood cells, such as the contaminating w hite cells in a platelet concentrate, is irradiated with ultraviolet radiation predominantely of a wavelength of 280 to 320 nanomet ers, and preferably at an intensity of 4 to 20 milliwatts per square cm. to provide a total energy exposure of typically 800 to 20,000 millijoules per square cm. of ultraviolet radiation. The white blood cells so processed substantially lose their capabilit y to set off an immune reaction in an alloimmunized patient. The white blood cells may preferably be placed into such film in a flat (10), flexible bag (10) made of poly(ethylene-vinyl acetate) plastic, with the flat (10), flexible bag (10) being stretched in a dir ection normal to the path of ultraviolet radiation. Novel irradiating devices (40) are also disclosed.

    IRRADIATION OF BLOOD PRODUCTS
    3.
    发明专利

    公开(公告)号:CA2031522A1

    公开(公告)日:1990-11-03

    申请号:CA2031522

    申请日:1990-01-17

    Applicant: BAXTER INT

    Abstract: A thin film or layer of white blood cells, such as the contaminating white cells in a platelet concentrate, is irradiated with ultraviolet radiation predominately of a wavelength of 280 to 320 nanometers, and preferably at an intensity of 4 to 20 milliwatts per square cm. to provide a total energy exposure of typically 800 to 20,000 millijoules per square cm. of ultraviolet radiation. The white blood cells so produced substantially lose their capability to set off an immune reaction in an alloimmunized patient. The white blood cells may preferably be placed into such film in a flat, flexible bag made of poly(ethylene-vinyl acetate) plastic, with the flat, flexible bag being stretched in a direction normal to the path of ultraviolet radiation. Novel irradiating devices are also disclosed.

    CONTROLLED ADMINISTRATION OF BENEFICIAL AGENT TO BLOOD

    公开(公告)号:CA1339088C

    公开(公告)日:1997-07-29

    申请号:CA582994

    申请日:1988-11-14

    Applicant: BAXTER INT

    Abstract: As one administers blood through a conduit into a container, the blood is passed in the conduit across the supply of beneficial agent, such as anticoagulant, to cause a controlled amount of beneficial agent to enter the passing blood in a manner that is substantially uniform over time. The beneficial agent is typically in dry form until it enters into contact with the blood. Accordingly, no substantial portion of the blood is exposed to a significantly higher concentration of the beneficial agent than other portions of the blood.

Patent Agency Ranking